Pitch&Connect #2 – Showcasing Next-Generation Therapeutics and Technologies

Discover bold innovations shaping the future of therapeutics and technology,
and seize the opportunity to connect with leading minds across the Basel Area ecosystem.

What can you expect?

– Short and inspiring pitches
– A friendly networking moment over a sandwich lunch
– The opportunity to connect with passionate individuals

About the startups:

Swiss Biome Institute operates as a contract research organization (CRO) specializing in epigenetic testing.
The company aims to transform centenarian microbiome discoveries into longevity applications by leveraging Switzerland’s expertise in epigenetics.

JURA Bio Inc. is a pioneering preclinical genomic medicine development company with the mission of improving the efficacy, safety, and time-to-development of genomic medicines.
Its platform merges probabilistic machine learning and synthetic biology to design, build and learn from the world’s largest physical libraries of immune receptors and their targets.

Salvina Therapeutics AG is developing new therapies to break efficacy ceilings in inflammatory and autoimmune diseases.
They have unlocked a novel approach for selectively targeting TNF and other TNF superfamily (TNFSF) members, resulting in the generation of antibodies with a highly innovative mode of action.
These have the potential to significantly improve the benefit/risk ratio of TNFSF targeting in certain diseases and enable bispecific therapies that have not been developable to date.